Similar Papers

Paper Title
Journal
Date
Author
Yasutomi Nishizuka's Discovery of Protein Kinase C
Nicole Kresge ... Robert L Hill
Journal of Biological Chemistry | VOL. 285
Nicole Kresge, et. al.Nicole Kresge ... Robert L Hill
01 Oct 2010
Role of protein kinase C in ischemic preconditioning: player or spectator?
Gavin Brooks ... David J Hearse
Circulation research | VOL. 79
Gavin Brooks, et. al.Gavin Brooks ... David J Hearse
01 Sep 1996
Proteolytic activation of calcium-activated, phospholipid-dependent protein kinase by calcium-dependent neutral protease.
A Kishimoto ... M Shiota
Journal of Biological Chemistry | VOL. 258
A Kishimoto, et. al.A Kishimoto ... M Shiota
01 Jan 1982
Signaling Mechanisms in Ischemic Preconditioning
Hossein Ardehali
Circulation Research | VOL. 99
Hossein ArdehaliHossein Ardehali
13 Oct 2006
View more papers

More From: Cancer

Paper Title
Journal
Date
Author
Pembrolizumab with chemoradiotherapy followed by pembrolizumab for stage III–IVa cervical cancer: is the ENGOT‐cx11/GOG‐3047/KEYNOTE‐A18 trial practice changing?
Bart M F Penninx ... John‐John B Schnog
Cancer | VOL. 131
Bart M F Penninx, et. al.Bart M F Penninx ... John‐John B Schnog
06 Feb 2025
EXPRESSION OF CONCERN: Mechanisms of Synthetic Serine Protease Inhibitor (FUT‐175)‐Mediated Cell Death
-
Cancer | VOL. 131
--
06 Feb 2025
A phase 2 basket study of talabostat, a small-molecule inhibitor of dipeptidyl peptidases, administered in combination with pembrolizumab in patients with advanced solid cancers.
Jibran Ahmed ... Aung Naing
Cancer | VOL. 131
Jibran Ahmed, et. al.Jibran Ahmed ... Aung Naing
01 Feb 2025
Men face substantial lifelong risk of oral HPV infection: A study provides information on rates of newly acquired oral HPV infections and associated risk factors for acquiring HPV infections in a multinational cohort of more than 3000 men.
Mary Beth Nierengarten
Cancer | VOL. 131
Mary Beth NierengartenMary Beth Nierengarten
01 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.